Organon logo.
Organon announced that it will move its 340B contract pharmacy claims review and policy oversight duties to Kalderos’ Truzo platform as of May 1.

Organon to Move to Truzo, Becomes 3rd Drugmaker to Use Kalderos’ Platform for 340B Contract Pharmacy Restrictions

The New Jersey-based spin-off of pharmaceutical giant Merck announced Wednesday that it will become the third drugmaker to utilize a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live